Susan K Parsons

37PUBLICATIONS
159CO-AUTHORS
Haematological tumoursPredictive and prognostic markersFeminist and queer theoryCross-sectional analysisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jan 09, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.

Sharon M Castellino, Hongli Li, Alex F Herrera

|Dec 12, 2025
Cancer-Related Impacts on Employment and Strategies for Support Among Long-Term Young Adult Survivors of Hematologic Malignancies.

Timothy J D Ohlsen, Rachel Murphy-Banks, Melissa P Beauchemin

|Nov 19, 2025
Epic Patient Portal Adoption Among Vulnerable Oncology Patients in the Era of Oral Anticancer Medications.

Yenong Cao, Marie Noelle Bate Baiyee, Johnson Ching

|Jun 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.

Sarah C Rutherford, Hongli Li, Alex F Herrera

Pageof 7